Presentatör: Hans Jeppsson, CFO Presentation, datum och tid: 26 november kl 16:15 CET
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients
C21 shows promise against COVID-19 where other drugs have failed
Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Report on the ATTRACT study
MedNous article: A surprise finding in the clinic